Adaptive Biotechnologies Corporation
ADPT
$3.54
-$0.07-1.94%
Headlines
5/18/2024
-
Ticker Report
5/18/2024
-
Tickeron - Stocks
5/17/2024
-
Tickeron - Stocks
5/15/2024
-
ETF Channel
5/14/2024
-
Tickeron - Stocks
5/13/2024
-
Zolmax
5/12/2024
-
TipRanks Financial Blog
5/10/2024
-
Zolmax
5/10/2024
-
Zolmax
5/10/2024
-
Tickeron - Stocks
5/10/2024
-
Tickeron - Stocks
5/8/2024
-
Fool.com Headlines
5/8/2024
-
Simply Wall St
5/8/2024
-
Insider Monkey
5/8/2024
-
Ticker Report
5/8/2024
-
The Fly
5/8/2024
-
GuruFocus
5/8/2024
-
GuruFocus
5/8/2024
-
SeekingAlpha
5/8/2024
-
SeekingAlpha
5/7/2024
-
Zacks Investment Research
5/7/2024
-
GuruFocus
5/7/2024
-
Zacks Investment Research
5/7/2024
-
SeekingAlpha.com: All News
5/7/2024
-
The Fly
Filings
Tuesday, May 7, 2024
Sunday, March 31, 2024
Beginning of August (est)
Price History
--
Corporate Info
206 659 0067
1165 Eastlake Avenue East
Seattle, WA 98109
Seattle, WA 98109
Business Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing...
more